SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: billkirn who wrote (1076)7/30/1999 9:52:00 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 1972
 
All: A couple thoughts. A buyout is very likely due to the number of partnerings VICL has established. Great validation of technology, low burn rate, but trying to unwind the partnerings would be tough. Very disappointed the WSJ article did not mention VICL (I read it on the plane) But on squakbox this a.m. Joe Kearnan (sp?) spoke of VICL and it's naked DNA tech (I think he does most of the biotech comments there)

Finally on the P&D reference - how totally absurd. P&D's are a OTC phenomenon, where the company it self puts out great sounding (to the unlearned) hinting about wonderfull things to come, negociatins, joint ventures... but never hard contract/$s kinda stuff.

VICL and MRK do have a clear licensing agreement, involving real $s. One of the reasons they are so strong financially for a company that has several clinical trials going and no drugs/vaccines on the market yet.

P&D? Get real. IMSCO Scott

Vical jumps on report of Merck work on AIDS vaccine

biz.yahoo.com



To: billkirn who wrote (1076)8/1/1999 12:10:00 AM
From: Scott H. Davis  Read Replies (1) | Respond to of 1972
 
FFI on the technical front, at one TA service I use, VICL generated 4 signals on 7/30 (unusual to have 4 in a day) 3/4 were bullish:

Williams Accumulation/Distribution
Pivot Point
Positive Volume Index
(Negative Volume Index was bearish)

From WSRN
equities.barchart.com

From another site
Moving Average Convergence/Divergence (MACD) indicates a BULLISH TREND
Chart pattern indicates a STRONG UPWARD TREND
Relative Strength is BULLISH
Up/Down volume pattern indicates that the stock is under ACCUMULATION
The 50 day MOVING AVERAGE is rising which is BULLISH
The 200 day MOVING AVERAGE is rising which is BULLISH

RECOMMENDATION

STOCK IS A BUY

DMI also looks bullish to me. But, since I'm not a professional trader, I may be pretty clueless. Scott